TherapeuticsMD Ownership 2024 | Who Owns TherapeuticsMD Now?
Institutional Ownership
0.84%
Insider Ownership
1.77%
Retail Ownership
97.39%
Institutional Holders
11.00
TherapeuticsMD Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RUBRIC CAPITAL MANAGEMENT LP | 10.34% | 0.05% | 1,192,191 | - | - | 1,919,428 | Jun 30, 2024 |
| CLEARLINE CAPITAL LP | 5.52% | 0.03% | 636,622 | 101,282 | 18.92% | 1,024,961 | Jun 30, 2024 |
| TEJARA CAPITAL LTD | 3.49% | 0.24% | 401,937 | - | - | 647,119 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.36% | - | 387,582 | - | - | 624,007 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 2.34% | 0.08% | 270,160 | -2,000 | -0.73% | 434,958 | Jun 30, 2024 |
| MORGAN STANLEY | 1.14% | - | 131,601 | -91 | -0.07% | 211,877 | Jun 30, 2024 |
| BLACKROCK INC. | 1.09% | - | 125,152 | -10,627 | -7.83% | 201,495 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.83% | - | 95,477 | 10,689 | 12.61% | 153,758 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.29% | 0.00% | 34,000 | -5,100 | -13.04% | 54,740 | Jun 30, 2024 |
| STATE STREET CORP | 0.26% | - | 30,100 | - | - | 48,461,000 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 0.19% | - | 22,470 | - | - | 36,177 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.14% | - | 16,457 | - | - | 26,496,000 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | 0.12% | 0.00% | 14,359 | 14,359 | 100.00% | 23,118 | Jun 30, 2024 |
| J. GOLDMAN & CO LP | 0.12% | 0.00% | 13,562 | - | - | 21,835 | Jun 30, 2024 |
| GABELLI FUNDS LLC | 0.10% | 0.00% | 12,000 | - | - | 19,320 | Jun 30, 2024 |
| UBS GROUP AG | 0.08% | - | 9,116 | 1,302 | 16.66% | 14,677 | Jun 30, 2024 |
| FMR LLC | 0.07% | - | 8,289 | - | - | 13,345 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 3,534 | 1,897 | 115.88% | 5,690 | Jun 30, 2024 |
| NATIONAL BANK OF CANADA /FI/ | 0.01% | - | 610 | -110 | -15.28% | 1,031 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 487 | 87 | 21.75% | 784 | Jun 30, 2024 |
TherapeuticsMD's largest institutional shareholder is RUBRIC CAPITAL MANAGEMENT LP, holding 10.34% of the company's total share outstanding, currently valued at $1.92M. The top 10 institutional shareholders own together 28.66% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TEJARA CAPITAL LTD | 3.49% | 0.24% | 401,937 | - | - | 647,119 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 2.34% | 0.08% | 270,160 | -2,000 | -0.73% | 434,958 | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 10.34% | 0.05% | 1,192,191 | - | - | 1,919,428 | Jun 30, 2024 |
| CLEARLINE CAPITAL LP | 5.52% | 0.03% | 636,622 | 101,282 | 18.92% | 1,024,961 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.29% | 0.00% | 34,000 | -5,100 | -13.04% | 54,740 | Jun 30, 2024 |
| J. GOLDMAN & CO LP | 0.12% | 0.00% | 13,562 | - | - | 21,835 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | 0.12% | 0.00% | 14,359 | 14,359 | 100.00% | 23,118 | Jun 30, 2024 |
| GABELLI FUNDS LLC | 0.10% | 0.00% | 12,000 | - | - | 19,320 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 3,534 | 1,897 | 115.88% | 5,690 | Jun 30, 2024 |
| ACTIVEST WEALTH MANAGEMENT | 0.00% | - | 40 | 40 | 100.00% | 64 | Jun 30, 2024 |
| MORGAN STANLEY | 1.14% | - | 131,601 | -91 | -0.07% | 211,877 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.83% | - | 95,477 | 10,689 | 12.61% | 153,758 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.36% | - | 387,582 | - | - | 624,007 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 0.19% | - | 22,470 | - | - | 36,177 | Jun 30, 2024 |
| PRINCIPAL SECURITIES, INC. | 0.00% | - | 126 | - | - | 203 | Jun 30, 2024 |
| IFP ADVISORS, INC | 0.00% | - | 80 | 20 | 33.33% | 129 | Jun 30, 2024 |
| BLACKROCK INC. | 1.09% | - | 125,152 | -10,627 | -7.83% | 201,495 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.14% | - | 16,457 | - | - | 26,496,000 | Jun 30, 2024 |
| UBS GROUP AG | 0.08% | - | 9,116 | 1,302 | 16.66% | 14,677 | Jun 30, 2024 |
| GUARDIAN WEALTH MANAGEMENT, INC. | - | - | 2 | - | - | 3 | Jun 30, 2024 |
The largest TherapeuticsMD shareholder by % of total assets is TEJARA CAPITAL LTD. The company owns 401.94K shares of TherapeuticsMD (TXMD), representing 0.24% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CLEARLINE CAPITAL LP | 5.52% | 0.03% | 636,622 | 101,282 | 18.92% | 1,024,961 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | 0.12% | 0.00% | 14,359 | 14,359 | 100.00% | 23,118 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.83% | - | 95,477 | 10,689 | 12.61% | 153,758 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 3,534 | 1,897 | 115.88% | 5,690 | Jun 30, 2024 |
| UBS GROUP AG | 0.08% | - | 9,116 | 1,302 | 16.66% | 14,677 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 487 | 87 | 21.75% | 784 | Jun 30, 2024 |
| ACTIVEST WEALTH MANAGEMENT | 0.00% | - | 40 | 40 | 100.00% | 64 | Jun 30, 2024 |
| IFP ADVISORS, INC | 0.00% | - | 80 | 20 | 33.33% | 129 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | 2 | - | - | 4 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 293 | - | - | 471 | Jun 30, 2024 |
| EVERSOURCE WEALTH ADVISORS, LLC | - | - | 1 | - | - | 2 | Jun 30, 2024 |
| HARBOUR INVESTMENTS, INC. | 0.00% | - | 8 | - | - | 13 | Jun 30, 2024 |
| ASPIRE PRIVATE CAPITAL, LLC | - | - | 1 | - | - | 2 | Jun 30, 2024 |
| FMR LLC | 0.07% | - | 8,289 | - | - | 13,345 | Jun 30, 2024 |
| HUNTINGTON NATIONAL BANK | 0.00% | - | 120 | - | - | 193 | Jun 30, 2024 |
| STATE STREET CORP | 0.26% | - | 30,100 | - | - | 48,461,000 | Jun 30, 2024 |
| GUARDIAN WEALTH MANAGEMENT, INC. | - | - | 2 | - | - | 3 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.14% | - | 16,457 | - | - | 26,496,000 | Jun 30, 2024 |
| PRINCIPAL SECURITIES, INC. | 0.00% | - | 126 | - | - | 203 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 0.19% | - | 22,470 | - | - | 36,177 | Jun 30, 2024 |
As of Jun 30 2024, TherapeuticsMD's largest institutional buyer is CLEARLINE CAPITAL LP. The company purchased 101.28K stocks of TXMD, valued at $1.02M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CLEAR HARBOR ASSET MANAGEMENT, LLC | - | - | - | -25,809 | -100.00% | - | Jun 30, 2024 |
| PROSPERITY CONSULTING GROUP, LLC | - | - | - | -24,500 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -13,700 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | 1.09% | - | 125,152 | -10,627 | -7.83% | 201,495 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -10,154 | -100.00% | - | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.29% | 0.00% | 34,000 | -5,100 | -13.04% | 54,740 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 2.34% | 0.08% | 270,160 | -2,000 | -0.73% | 434,958 | Jun 30, 2024 |
| BANQUE CANTONALE VAUDOISE | - | - | - | -1,000 | -100.00% | - | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 56 | -980 | -94.59% | 90 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -517 | -100.00% | - | Jun 30, 2024 |
| US BANCORP \DE\ | 0.00% | - | 246 | -164 | -40.00% | 396 | Jun 30, 2024 |
| NATIONAL BANK OF CANADA /FI/ | 0.01% | - | 610 | -110 | -15.28% | 1,031 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.00% | - | 171 | -96 | -35.96% | 275 | Jun 30, 2024 |
| MORGAN STANLEY | 1.14% | - | 131,601 | -91 | -0.07% | 211,877 | Jun 30, 2024 |
| OLD POINT TRUST & FINANCIAL SERVICES N A | - | - | - | -50 | -100.00% | - | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.00% | - | 122 | -18 | -12.86% | 196 | Jun 30, 2024 |
| ASSETMARK, INC | - | - | - | -1 | -100.00% | - | Jun 30, 2024 |
| TEJARA CAPITAL LTD | 3.49% | 0.24% | 401,937 | - | - | 647,119 | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 10.34% | 0.05% | 1,192,191 | - | - | 1,919,428 | Jun 30, 2024 |
| J. GOLDMAN & CO LP | 0.12% | 0.00% | 13,562 | - | - | 21,835 | Jun 30, 2024 |
As of Jun 30 2024, TherapeuticsMD's biggest institutional seller is CLEAR HARBOR ASSET MANAGEMENT, LLC. The company sold -25.81K shares of TXMD, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TWO SIGMA SECURITIES, LLC | 0.12% | 0.00% | 14,359 | 14,359 | 100.00% | 23,118 | Jun 30, 2024 |
| ACTIVEST WEALTH MANAGEMENT | 0.00% | - | 40 | 40 | 100.00% | 64 | Jun 30, 2024 |
TherapeuticsMD's largest new institutional shareholder by number of shares is TWO SIGMA SECURITIES, LLC, purchased 14.36K shares, valued at $23.12K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CLEAR HARBOR ASSET MANAGEMENT, LLC | - | - | - | -25,809 | -100.00% | - | Jun 30, 2024 |
| PROSPERITY CONSULTING GROUP, LLC | - | - | - | -24,500 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -13,700 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -10,154 | -100.00% | - | Jun 30, 2024 |
| BANQUE CANTONALE VAUDOISE | - | - | - | -1,000 | -100.00% | - | Jun 30, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -517 | -100.00% | - | Jun 30, 2024 |
| OLD POINT TRUST & FINANCIAL SERVICES N A | - | - | - | -50 | -100.00% | - | Jun 30, 2024 |
| ASSETMARK, INC | - | - | - | -1 | -100.00% | - | Jun 30, 2024 |
TherapeuticsMD's largest sold out institutional shareholder by shares sold is CLEAR HARBOR ASSET MANAGEMENT, LLC, sold -25.81K shares, valued at -, as of undefined.
TherapeuticsMD Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| BNY MELLON VARIABLE INVESTMENT FUND | 6.41% | 1,553,717 | - | - | Mar 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 2.24% | 8,166,457 | - | - | Mar 31, 2024 |
| JP MORGAN MUTUAL FUND INVESTMENT TRUST | 1.26% | 4,764,678 | - | - | Dec 31, 2023 |
| FIDELITY DESTINY PORTFOLIOS | 0.90% | 1,966,431 | - | - | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.55% | 4,630,140 | - | - | Jan 31, 2024 |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 0.54% | 3,831,500 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.46% | 5,053,503 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.12% | 275,500 | - | - | Mar 28, 2024 |
| Vericimetry Funds | 0.11% | 9,620 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.10% | 619,846 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.09% | 54,921 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND VI | 0.07% | 401,600 | - | - | Mar 31, 2024 |
| Nushares ETF Trust | 0.05% | 366,440 | - | - | Jan 31, 2024 |
| IndexIQ ETF Trust | 0.05% | 112,080 | - | - | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.05% | 10,557 | - | - | Mar 31, 2024 |
| Gabelli 787 Fund, Inc. | 0.05% | 4,000 | - | - | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.04% | 121,939 | - | - | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.03% | 14,061,255 | - | - | Mar 31, 2024 |
| JNL VARIABLE FUND LLC | 0.03% | 165,962 | - | - | Mar 31, 2020 |
| T. Rowe Price Index Trust, Inc. | 0.02% | 519,234 | - | - | Feb 29, 2024 |
| AIM GROWTH SERIES (INVESCO GROWTH SERIES) | 0.02% | 676,749 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.02% | 858,241 | - | - | Feb 29, 2024 |
| BRIDGEWAY FUNDS INC | 0.02% | 39,100 | -2,900 | -6.90% | Mar 28, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.01% | 120,000 | - | - | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.01% | 693,298 | - | - | Mar 31, 2024 |
| AMG Funds I | 0.01% | 25,976 | - | - | Jan 31, 2024 |
| GDL FUND | 0.01% | 17,000 | - | - | Dec 29, 2023 |
| Calvert Variable Products, Inc. | 0.01% | 27,432 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.01% | 5,268 | - | - | Mar 31, 2024 |
| MASSMUTUAL PREMIER FUNDS | 0.01% | 280,391 | - | - | Dec 31, 2023 |
| FIDELITY COVINGTON TRUST | 0.01% | 177,800 | - | - | Jan 31, 2024 |
| BNY MELLON FUNDS TRUST | 0.01% | 682,435 | - | - | Aug 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.01% | 274,286 | - | - | Mar 31, 2024 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.01% | 128,167 | - | - | Feb 29, 2024 |
| VALIC Co II | 0.01% | 263,260 | - | - | Feb 28, 2021 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 385,742 | - | - | Feb 29, 2024 |
| JPMORGAN TRUST II | 0.01% | 5,917,540 | - | - | Feb 29, 2024 |
| VANGUARD WORLD FUND | 0.00% | 1,199,554 | - | - | Feb 29, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.00% | 7,774 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 20,300 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 129,363 | - | - | Mar 31, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 370,978 | - | - | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 48,021 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 1,948 | - | - | Apr 30, 2021 |
| JPMORGAN INSURANCE TRUST | 0.00% | 43,800 | - | - | Mar 31, 2023 |
| GABELLI INVESTOR FUNDS INC | 0.00% | 8,000 | -2,000 | -20.00% | Dec 29, 2023 |
| COLUMBIA FUNDS VARIABLE INSURANCE TRUST | 0.00% | 1,739,570 | - | - | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 1,591,786 | - | - | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 7,039 | - | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 110,781 | - | - | Jan 31, 2024 |
| PFM Multi-Manager Series Trust | 0.00% | 1,900 | - | - | Dec 31, 2023 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 123,100 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 209,957 | - | - | Mar 28, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 28,331 | - | - | Mar 31, 2024 |
| FLEXSHARES TRUST | 0.00% | 100,392 | - | - | Jan 31, 2024 |
| Voya INVESTORS TRUST | 0.00% | 68,300 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 14,623 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 242,731 | - | - | Feb 29, 2024 |
| FIDELITY HASTINGS STREET TRUST | 0.00% | 8,027,214 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 371,891 | -122,234 | -24.74% | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 3,721 | - | - | Dec 31, 2023 |
| EQ ADVISORS TRUST | 0.00% | 1,056,363 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 3,245,522 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 4,556 | - | - | Feb 29, 2024 |
| ProFunds | 0.00% | 8,336 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 1,370,063 | - | - | Feb 29, 2024 |
| MML Series Investment Fund II | 0.00% | 127,340 | - | - | Dec 31, 2023 |
| COLUMBIA FUNDS SERIES TRUST I | 0.00% | 3,100,390 | - | - | Feb 29, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 69,245 | - | - | Mar 28, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 36,454 | - | - | Feb 29, 2024 |
| Series Portfolios Trust | 0.00% | 3,419 | - | - | Jan 31, 2024 |
| VALIC Co I | 0.00% | 151,742 | - | - | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 2,058 | - | - | Dec 31, 2023 |
| Direxion Shares ETF Trust | 0.00% | 70,206 | - | - | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 114,894 | - | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 12,500 | - | - | Mar 28, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 37,248 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 77,247 | -360 | -0.46% | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 48,246 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 44,679 | - | - | Jan 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 375 | - | - | Dec 31, 2023 |
| SUNAMERICA SERIES TRUST | 0.00% | 117,892 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 858,500 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 5,668 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 56,991 | - | - | Jan 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 23,798 | - | - | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 5,486 | - | - | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 5,677 | - | - | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 185,601 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 7,060 | - | - | Jan 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 148,607 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 15,457 | - | - | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 330,127 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 202,077 | - | - | Mar 31, 2024 |
| FIRST EAGLE FUNDS | 0.00% | 1,174,280 | - | - | Jan 31, 2024 |
| ETF Series Solutions | 0.00% | 1,890 | - | - | Jan 31, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 7,345 | - | - | Jan 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 45,821 | - | - | Feb 29, 2024 |
| SPDR SERIES TRUST | 0.00% | 2,206,880 | - | - | Mar 31, 2024 |
| VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 0.00% | 88,146 | - | - | Jan 31, 2024 |
TherapeuticsMD's largest mutual fund holder by % of total assets is "BNY MELLON VARIABLE INVESTMENT FUND", owning 1.55M shares, compromising 6.41% of its total assets.
TherapeuticsMD Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 11 | -74.42% |
| 31 Mar, 24 | 43 | 16.22% |
| 31 Dec, 23 | 37 | - |
| 30 Sep, 23 | 37 | -13.95% |
| 30 Jun, 23 | 43 | 4.88% |
| 31 Mar, 23 | 41 | -18.00% |
| 31 Dec, 22 | 50 | 35.14% |
| 30 Sep, 22 | 37 | -27.45% |
| 30 Jun, 22 | 51 | 2450.00% |
| 31 Mar, 22 | 2 | 100.00% |
| 31 Dec, 21 | 1 | - |
As of 30 Jun 24, 11 institutions are holding TherapeuticsMD's shares, representing a decrease of -74.42% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 96,832 | -97.13% |
| 31 Mar, 24 | 3,377,177 | 3.85% |
| 31 Dec, 23 | 3,251,847 | 9.41% |
| 30 Sep, 23 | 2,972,070 | -1.18% |
| 30 Jun, 23 | 3,007,650 | -2.26% |
| 31 Mar, 23 | 3,077,324 | -10.50% |
| 31 Dec, 22 | 3,438,389 | 69.04% |
| 30 Sep, 22 | 2,034,094 | 0.73% |
| 30 Jun, 22 | 2,019,273 | 18596.97% |
| 31 Mar, 22 | 10,800 | 8.00% |
| 31 Dec, 21 | 10,000 | - |
TherapeuticsMD (TXMD) has 96.83K shares outstanding as of 30 Jun 24, down -97.13% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 0.84% | 0.10% |
| 31 Mar, 24 | 29.29% | 3.17% |
| 31 Dec, 23 | 30.39% | 3.59% |
| 30 Sep, 23 | 29.08% | 3.06% |
| 30 Jun, 23 | 30.84% | 3.10% |
| 31 Mar, 23 | 31.55% | 2.18% |
| 31 Dec, 22 | 38.09% | 7.89% |
| 30 Sep, 22 | 21.96% | 4.12% |
| 30 Jun, 22 | 23.08% | 368127356.00% |
| 31 Mar, 22 | 0.00% | 39920.00% |
| 31 Dec, 21 | 0.00% | - |
As of 30 Jun 24, TherapeuticsMD is held by 0.84% institutional shareholders, representing a 0.10% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 3 | -76.92% |
| 31 Mar, 24 | 13 | 85.71% |
| 31 Dec, 23 | 7 | -36.36% |
| 30 Sep, 23 | 11 | -8.33% |
| 30 Jun, 23 | 12 | - |
| 31 Mar, 23 | 12 | -55.56% |
| 31 Dec, 22 | 27 | 80.00% |
| 30 Sep, 22 | 15 | -66.67% |
| 30 Jun, 22 | 45 | 4400.00% |
| 31 Mar, 22 | 1 | - |
| 31 Dec, 21 | 1 | - |
3 institutional shareholders have increased their position in TXMD stock as of 30 Jun 24 compared to 13 in the previous quarter (a -76.92% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 3 | -66.67% |
| 31 Mar, 24 | 9 | -30.77% |
| 31 Dec, 23 | 13 | 116.67% |
| 30 Sep, 23 | 6 | -14.29% |
| 30 Jun, 23 | 7 | -30.00% |
| 31 Mar, 23 | 10 | -9.09% |
| 31 Dec, 22 | 11 | 10.00% |
| 30 Sep, 22 | 10 | - |
| 30 Jun, 22 | - | - |
| 31 Mar, 22 | - | - |
| 31 Dec, 21 | - | - |
3 institutional shareholders have reduced their position in TXMD stock as of 30 Jun 24 compared to 9 in the previous quarter (a -66.67% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 11 | -74.42% | 96,832 | -97.13% | 0.84% | 0.10% | 3 | -76.92% | 3 | -66.67% |
| 31 Mar, 24 | 43 | 16.22% | 3,377,177 | 3.85% | 29.29% | 3.17% | 13 | 85.71% | 9 | -30.77% |
| 31 Dec, 23 | 37 | - | 3,251,847 | 9.41% | 30.39% | 3.59% | 7 | -36.36% | 13 | 116.67% |
| 30 Sep, 23 | 37 | -13.95% | 2,972,070 | -1.18% | 29.08% | 3.06% | 11 | -8.33% | 6 | -14.29% |
| 30 Jun, 23 | 43 | 4.88% | 3,007,650 | -2.26% | 30.84% | 3.10% | 12 | - | 7 | -30.00% |
| 31 Mar, 23 | 41 | -18.00% | 3,077,324 | -10.50% | 31.55% | 2.18% | 12 | -55.56% | 10 | -9.09% |
| 31 Dec, 22 | 50 | 35.14% | 3,438,389 | 69.04% | 38.09% | 7.89% | 27 | 80.00% | 11 | 10.00% |
| 30 Sep, 22 | 37 | -27.45% | 2,034,094 | 0.73% | 21.96% | 4.12% | 15 | -66.67% | 10 | - |
| 30 Jun, 22 | 51 | 2450.00% | 2,019,273 | 18596.97% | 23.08% | 368127356.00% | 45 | 4400.00% | - | - |
| 31 Mar, 22 | 2 | 100.00% | 10,800 | 8.00% | 0.00% | 39920.00% | 1 | - | - | - |
| 31 Dec, 21 | 1 | - | 10,000 | - | 0.00% | - | 1 | - | - | - |
TherapeuticsMD Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of TherapeuticsMD's stock was made by Walker Marlan D on Dec 07 2023, selling 14,500 shares at $2.31 per share (valued at $33.50K).
TherapeuticsMD Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q4 2023 | 2 | 3 | 66.67% |
| Q3 2023 | 4 | - | - |
| Q2 2023 | 8 | 9 | 88.89% |
| Q1 2023 | 9 | 6 | 150.00% |
| Q4 2022 | 13 | 17 | 76.47% |
| Q3 2022 | 12 | 5 | 240.00% |
| Q1 2022 | 9 | 1 | 900.00% |
| Q4 2021 | 5 | 2 | 250.00% |
| Q3 2021 | 36 | 18 | 200.00% |
| Q2 2021 | 6 | 10 | 60.00% |
| Q1 2021 | 2 | 7 | 28.57% |
| Q4 2020 | 3 | - | - |
| Q3 2020 | - | 4 | - |
| Q2 2020 | 20 | 1 | 2000.00% |
| Q1 2020 | 10 | 4 | 250.00% |
| Q4 2019 | 4 | - | - |
| Q3 2019 | 16 | - | - |
| Q2 2019 | 10 | - | - |
| Q1 2019 | - | 3 | - |
| Q4 2018 | 24 | 76 | 31.58% |
2 total buy trades, and 3 total sell trades (buy/sell ratio of 0.67%) were made by TherapeuticsMD's insiders, as of Q4 2023.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q4 2023 | - | 2 | - |
| Q3 2023 | - | - | - |
| Q2 2023 | - | 2 | - |
| Q1 2023 | - | 4 | - |
| Q4 2022 | 4 | 7 | 57.14% |
| Q3 2022 | 3 | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | 1 | 1 | 100.00% |
| Q3 2021 | 5 | 1 | 500.00% |
| Q2 2021 | 1 | 5 | 20.00% |
| Q1 2021 | - | - | - |
| Q4 2020 | - | - | - |
| Q3 2020 | - | - | - |
| Q2 2020 | 8 | - | - |
| Q1 2020 | - | 1 | - |
| Q4 2019 | 4 | - | - |
| Q3 2019 | 10 | - | - |
| Q2 2019 | 2 | - | - |
| Q1 2019 | - | 1 | - |
| Q4 2018 | - | 36 | - |
As of Q4 2023, Insider owners conducted 0 open market buy trades and 2 open market sell trades of TherapeuticsMD's stocks.
TherapeuticsMD Peer Ownership
| Ticker | Company |
|---|---|
| EVOK | Evoke Pharma, Inc. |
| TKNO | Alpha Teknova, Inc. |
| ANIP | ANI Pharmaceuticals, Inc. |
| AQST | Aquestive Therapeutics, Inc. |
| LFCR | Lifecore Biomedical, Inc. |
| ORGO | Organogenesis Holdings Inc. |
| GHSI | Guardion Health Sciences, Inc. |
| IRWD | Ironwood Pharmaceuticals, Inc. |
| ACRX | Talphera, Inc. |
| PTPI | Petros Pharmaceuticals, Inc. |
| CPIX | Cumberland Pharmaceuticals Inc. |
| ADMP | Adamis Pharmaceuticals Corporation |
| CYTH | Cyclo Therapeutics, Inc. |
| PRFX | PainReform Ltd. |
| AGRX | Agile Therapeutics, Inc. |
| ALKS | Alkermes plc |
| EGRX | Eagle Pharmaceuticals, Inc. |
TXMD Ownership FAQ
Who Owns TherapeuticsMD?
TherapeuticsMD is owned by institutional shareholders (0.84%), insiders (1.77%), and public (97.39%). The largest institutional shareholder of TherapeuticsMD is RUBRIC CAPITAL MANAGEMENT LP (10.34% of total shares) and the top mutual fund owner is BNY MELLON VARIABLE INVESTMENT FUND (6.41% of total shares).
Who are the major institutional shareholders of TherapeuticsMD?
TherapeuticsMD's major institutional shareholders are RUBRIC CAPITAL MANAGEMENT LP, CLEARLINE CAPITAL LP, TEJARA CAPITAL LTD, VANGUARD GROUP INC, and ADAR1 CAPITAL MANAGEMENT, LLC. The top five shareholders own together 25.05% of the company's share outstanding.
How many TherapeuticsMD shareholders are there?
As of Jun 2024, there are 11 institutional shareholders of TherapeuticsMD.
What percentage of TherapeuticsMD is owned by RUBRIC CAPITAL MANAGEMENT LP?
RUBRIC CAPITAL MANAGEMENT LP owns 1.19M shares of TherapeuticsMD, representing 10.34% of the company's total shares outstanding, valued at $1.92M (as of Jun 2024).
What percentage of TherapeuticsMD is owned by CLEARLINE CAPITAL LP?
As of Jun 2024, CLEARLINE CAPITAL LP holds 636.62K shares of TherapeuticsMD (TXMD), compromising 5.52% of the company, valued at $1.02M.
What percentage of TherapeuticsMD is owned by TEJARA CAPITAL LTD?
TEJARA CAPITAL LTD is the third largest holder of TherapeuticsMD. The company owns 401.94K of the company's shares outstanding (worth $647.12K).